Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp270 | Genetics | ECTS2013

SQSTM1/P392L post-zygotic mutations in unrelated patients with Paget's disease of bone

Guay-Belanger Sabrina , Gagnon Edith , Morissette Jean , Brown Jacques P , Michou Laetitia

Introduction: Paget’s disease of bone (PDB) has an autosomal-dominant mode of inheritance in one-third of cases. The germinal SQSTM1/P392L mutation is the most frequent mutation, present in 40% of patients with a familial form of PDB, and 8% of unrelated patients. Fibrous dysplasia (FD) is a rare bone disorder, mono or polyostotic, caused by post-zygotic mutations in GNAS gene, for which a PCR-clamping method was developed to ease their detection and avo...

ba0002p76 | (1) | ICCBH2013

Final height and bone health in young adults, transplanted in childhood

Dyck Maria Van , Herman Jean , Lombaerts Rita

: This study analyses the long-term effect of rhGH on final height (FH) and bone health in renal transplanted patients.Twenty-one young adult patients, aged 17–26 years, were studied. Group A consisted of 15 patients (12 boys) who received rhGH during 3.0 years before transplantation. After transplantation three boys needed rhGH again for 3.5 years. In group B six patients (three boys) didn’t need rhGH before transplantation, three girls receiv...

ba0003pp349 | Osteoporosis: treatment | ECTS2014

Bisphosphonate-associated atypical femoral fracture, effect of teriparatide

Devogelaer Jean-Pierre , Berg Bruno Vande

Long-term bisphosphonate (BP) therapy can be complicated by atypical femoral fracture (AFF). A positive effect of teriparatide (TPTD) has been suggested.A woman (A, 81) with densitometric OP was put on alendronate (ALN) from 1997 until 2006, substituted by ibandronate (IBA), with an increase in FN-BMD of 6.6%. In August 2010, a fall from her standing height provoked a right transverse femoral fracture, which was operated. She was weaned from BP therapy. ...

ba0002p96 | (1) | ICCBH2013

Cross-sectional associations of sex steroids with bone maturation, bone mineral density and bone geometry in boys

Vandewalle Sara , Taes Youri , Fiers Tom , Toye Kaatje , Roggen Inge , Kaufman Jean-Marc , De Schepper Jean

Background: Although both testosterone and estrogens are considered essential for normal bone growth, epiphyseal maturation and bone mass accrual during adolescence, only very few data concerning the changes of estrogens, bone maturation, bone mineral density (BMD) and bone geometry in healthy boys at different pubertal stages have been published.Objectives: This study aimed to analyze the relationship between sex steroids and more especially estrogens a...

ba0001pp214 | Cell biology: osteoclasts and bone resorption | ECTS2013

Is a network of collagen fibers and blood vessels supporting pre-osteoclast trafficking from the bone marrow to the bone surface?

Thomas Levin Andersen , Helene Bjorg Kristensen , Delaisse Jean-Marie

Differentiation of osteoclast progenitor cells into mononucleated TRAcP+ pre-osteoclasts occurs in the bone marrow. But how are these cells dispatched to the future bone resorption sites? We hypothesized that the collagen type III/I-rich reticulin network of the bone marrow might provide a structural framework for localization and migration of differentiating pre-osteoclasts towards the bone surface. Therefore, adjacent sections from decalcified paraffin-embedded iliac crest b...

ba0005p39 | Bone biomechanics and quality | ECTS2016

Depth and location dependence of subchondral trabecular structure across the tibia in human osteoarthritic knee versus normal knee: a micro-CT study

Bouhadoun Hamid , Engelke Klaus , Laredo Jean Denis , Chappard Christine

Objective: To determine differences between osteoarthritic (OA) knees with normal knees for subchondral trabecular bone structure according to depth and location in the tibial plateau.Methods: In a population of 30 cadaveric left knees (18 women and 12 men, mean age: 79.1 years±8.2, range: 63–90) the Kellgren-Lawrence (KL) score was determined from post mortem radiographs: OA=KL≧2 (n=6 women, n=5 men) and controls=KL &#8804...

ba0001pp38 | Bone biomechanics and quality | ECTS2013

Bisphosphonate influence on bone quality at molecular level: study of human jaw bone sequesters by Raman microspectroscopy

Olejnik Cecile , Falgayrac Guillaume , During Alexandrine , Vieillard Marie-Helene , Maes Jean Michel , Cortet Bernard , Penel Guillaume

Bisphosphonates (BP) are used as anti-resorptive drugs in benign (osteoporosis) and malignant (myeloma, bone metastasis) bone diseases. Their high affinity for biominerals allows prolonged storage within bone. However information about molecular impact of BP on bone quality are missing. Better understanding of BP properties to optimize their clinical use is needed. The aim of this study was thus to investigate human bone physicochemical changes upon BP uptake.<p class="abs...

ba0001pp316 | Osteoporosis: evaluation and imaging | ECTS2013

Cortical and trabecular bone parameters from HR-Pqct images at the Tibia: a local comparison with synchrotron radiation micro-computed tomography

Ostertag Agnes , Peyrin Francoise , Fernandez Sylvie , Laredo Jean-Denis , De Vernejoul Marie-Christine , Chappard Christine

In clinical research protocols, HR-pQCT images (XtremCT Scanco, voxel size: 82 (μm3) are carried out to evaluate trabecular and cortical bone changes induced by osteoporosis and treatments. Micro-computed tomography (μ-CT) has become a standard tool for examination of trabecular and cortical bone in 3D.The purpose of this study is to evaluate the accuracy of cortical and trabecular measurements derived from HR-pQCT images with morpho...

ba0001pp400 | Osteoporosis: treatment | ECTS2013

Osteonecrosis of the jaw and non-malignant disease

Coudert Amelie , Lescaille Geraldine , Baaroun Vanessa , Azerad Jean , Cohen-Solal Martine , Berdal Ariane , Descroix Vianney

Bisphosphonates (BP) are powerful bone resorption inhibitors. They are used for the symptomatic treatment of malignant osteolytic bone disease (e.g. multiple myeloma and bone metastasis), as well as bone diseases associated with high bone resorption (e.g. postmenopausal osteoporosis, cortisone-induced osteoporosis). However, recent data showed that a rare, but serious, adverse effect of BP therapy is osteonecrosis of the jaw (BRONJ). Given the increasing number of persons rece...